Drug reference

somapacitin-beco

Mosby’s 2024 Nursing Drug Reference

Source: Mosby’s 2024 Nursing Drug Reference
PDF pages: 1222, 1223

Review source pages for extracted sections and age labels.

Overview

Names and pronunciation

(soe′ma-pas′i-tan Sogroya

PDF page 1222

Functional class

Func. class.: Growth hormone

PDF page 1222

Uses

USES: Growth hormone deficiency

PDF page 1222

Safety

Contraindications

CONTRAINDICATIONS Hypersensitivity, open heart/abdominal surgery, trauma; respiratory failure; malignancy; diabetic retinopathy

PDF page 1222

Dose and formulations

Dosage and routes

DOSAGE AND ROUTES Growth hormone deficiency Adult: SUBCUT 1.5 mg weekly; may increase by 0.5-1.5 mg/wk q2-4wk based on re- sponse, max 8 mg/wk HIGH ALERT

PDF pages 1222, 1223

Age labels are extracted for navigation. Check the complete source section and current local guidance before clinical use.

Drug reference

somapacitin-beco

Mosby’s 2024 Nursing Drug Reference

Source: Mosby’s 2024 Nursing Drug Reference
PDF pages: 1222, 1223

Review source pages for extracted sections and age labels.

Overview

Names and pronunciation

(soe′ma-pas′i-tan Sogroya

PDF page 1222

Functional class

Func. class.: Growth hormone

PDF page 1222

Uses

USES: Growth hormone deficiency

PDF page 1222

Safety

Contraindications

CONTRAINDICATIONS Hypersensitivity, open heart/abdominal surgery, trauma; respiratory failure; malignancy; diabetic retinopathy

PDF page 1222

Dose and formulations

Dosage and routes

DOSAGE AND ROUTES Growth hormone deficiency Adult: SUBCUT 1.5 mg weekly; may increase by 0.5-1.5 mg/wk q2-4wk based on re- sponse, max 8 mg/wk HIGH ALERT

PDF pages 1222, 1223

Age labels are extracted for navigation. Check the complete source section and current local guidance before clinical use.